CANF 13G

Company

Can-Fite BioPharma Ltd.

Filed

January 31, 2020

Accession Number

0001393825-20-000028

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →